Regulatory T Cells: History and Perspective

Methods in Molecular Biology

Volumn 707, Issue , 2011, Pages 3-17

  Sakaguchi, Shimon ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

CD25; Foxp3; Il 2; Immunological self tolerance; IPEX; Regulatory T cells; Suppressor T cells

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL; CYTOLOGY; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; ANTIGENS, CD4; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY;

EID: 79955703244     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61737-979-6_1     Document Type: Chapter

References (76)

1. Sakaguchi, S. (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455–458.
2. Gershon, R. K. and Kondo, K. (1970) Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18, 723–737.
3. Green, D. R., Flood, P. M. and Gershon, R. K. (1983) Immunoregulatory T-cell pathways. Annu. Rev. Immunol. 1,439–463.
4. Kronenberg, M., Steinmetz, M., Kobori, J., Kraig, E., Kapp, J. A., Pierce, C. W., et al. (1983) RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex. Proc. Natl. Acad. Sci. U.S.A. 80, 5704–5708.
5. Bloom B. R., Salgame, P. and Diamond, B. (1992) Revisiting and revising suppressor T cells. Immunol. Today 13, 131–136.
6. O’Garra, A. and Murphy, K. (1994) Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6, 458–466.
7. Chen, Y., Kuchroo, V. K., Inobe, J., Hafler, D. A. and Weiner, H. L. (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalitis. Science 265, 1237–1240.
8. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737–742.
9. Nishizuka, Y. and Sakakura, T. (1969) Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166, 753–755.
10. Kojima, A. and Prehn, R. T. (1981) Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 14, 15–27.
11. Penhale, W. J., Farmer, A., McKenna, R. P. and Irvine, W. J. (1973) Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin. Exp. Immunol. 15, 225–236.
12. Penhale, W. J., Stumbles, P. A., Huxtable, C. R., Sutherland, R. J. and Pethick, D. W. (1990) Induction of diabetes in PVG/c strain rats by manipulation of the immune system. Autoimmunity 7, 169–179.
13. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177, 627–636.
14. Sakaguchi, S., Takahashi, T. and Nishizuka, Y. (1982) Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 156, 1577–1586.
15. Penhale, W. J., Irvine, W. J., Inglis, J. R. and Farmer, A. (1976) Thyroiditis in T cell-depleted rats: suppression of the autoallergic response by reconstitution with normal lym-phoid cells. Clin. Exp. Immunol. 25, 6–16.
16. Sakaguchi, S., Takahashi, T. and Nishizuka, Y. (1982) Study on cellular events in post-thymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J. Exp. Med. 156, 1565–1576.
17. Sakaguchi, S., Fukuma, K., Kuribayashi, K. and Masuda, T. (1985) Organ-specific autoimmune diseases induced in mice by elimination of T-cell subset. I. Evidence for the active participation of T cells in natural self-tolerance: deficit of a T-cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161, 72–87.
18. bright normal T cells for the induction of thyroiditis. J. Immunol. 141, 105–113.
19. Smith, H., Lou, Y. H., lacy, P. and Tung, K. S. K. (1992) Tolerance mechanism in experimental ovarian and gastric autoimmune disease. J. Immunol. 149, 2212–2218.
20. low subset. J. Exp. Med. 172, 1701–1708.
21. McKeever, U., Mordes, J. P., Greiner, D. L., Appel, M. C., Rozing, J., Handler, E. S. and Rossini, A. A. (1990) Adoptive transfer of autoimmune diabetes and thyroiditis to athy-mic rats. Proc. Natl. Acad. Sci. U.S.A. 87, 7618–7622.
22. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M. (1995) Immunologic tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151–1164.
23. Asano, M., Toda, M., Sakaguchi, N. and Sakaguchi, S. (1996) Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387–396.
24. + T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5, 1461–1471.
25. + T cells. J. Exp. Med. 178, 237–244.
26. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317–5326.
27. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160, 1212–1218.
28. Qin, S., Cobbold, S. P., Pope, H., Elliott, J., Kioussis, D., Davies, J. and Waldmann, H. (1993) “Infectious” transplantation tolerance. Science 259, 974–977.
29. + suppressor cell and its mechanisms of action. J. Exp. Med. 171, 141–157.
30. Le Douarin, N., Corbel, C., Bandeira, A., Thomas-Vaslin, V., Modigliani, Y., Coutinho, A. and Salaun, J. (1996) Evidence for a thy-mus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol. Rev. 149, 35–53.
31. Waldmann, H., Adams, E., Fairchild, P. and Cobbold, S. (2006) Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 212, 301–313.
32. Schorle, H., Holtschke, T., Hunig, T., Schimpl, A. and Horak, I. (1991) Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621–624.
33. + T cell numbers. J. Immunol. 169, 4850–4860.
34. Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. and Alt, F. W. (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lym-phoid compartment. Immunity 3, 521–530.
35. Suzuki, H., Zhou, Y. W., Kato, M., Mak, T. W. and Nakashima, I. (1999) Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. J. Exp. Med. 190, 1561–1572.
36. Malek. T. R., Yu, A., Vincek, V., Scibelli, P. and Kong, L. (2002) CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17, 167–178.
37. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723–735.
38. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969–1980.
39. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287–296.
40. + suppressor T cells. J. Exp. Med. 193, F41–F46.
41. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., et al. (2001) Disruption of a new forkhead/ winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68–73.
42. Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C. and Bowcock, A. M. (2000) JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106, R75–R81.
43. Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J. L., Buist, N., et al. (2001) X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18–20.
44. Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20–21.
45. Hori, S., Nomura, T. and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061.
46. + regulatory T cells. Nat. Immunol. 4, 330–336.
47. + T regulatory cells. Nat. Immunol. 4, 337–342.
48. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G. and Rudensky, A. Y. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329–341.
49. Kim, J. M., Rasmussen, J. P. and Rudensky, A. Y. (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191–197.
50. Lahl, K., Loddenkemper, C., Drouin, C., Freyer, J., Arnason, J., Eberl, G., et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204, 57–63.
51. Roncador, G., Brown, P. J., Maestre, L., Hue, S., Martinez-Torrecuadrada, J. L., Ling, et al. (2005) Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur. J. Immunol. 35, 1681–1691.
52. Zheng, Y., Josefowicz, S. Z., Kas, A., Chu, T. T., Gavin, M. A. and Rudensky, A. Y. (2007) Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936–940.
53. Marson, A., Kretschmer, K., Frampton, G. M., Jacobsen, E. S., Polansky, J. K., MacIsaac, K. D., et al. (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445, 931–935.
54. Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C. et al. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375–387.
55. Ono, M., Yaguchi, H., Ohkura, N., Kitabayashi, I., Nagamura, Y., Nomura, T., et al. (2007) Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446, 685–689.
56. von Boehmer H. (2005) Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6, 338–344.
57. + regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9, 239–244.
58. Vignali, D. A., Collison, L. W. and Workman, C. J. (2008) How regulatory T cells work. Nat. Rev. Immunol. 8, 523–532.
59. + T regulatory cell-mediated suppression. Immunity 30, 636–645.
60. Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M. (2008) Regulatory T cells and immune tolerance. Cell 133, 775–787.
61. Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V.C., Beavo, J. A. and Rudensky, A. Y. (2007) Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771–775.
62. Lin, W., Haribhai, D., Relland, L. M., Truong, N., Carlson, M. R., Williams, C. B., and Chatila, T. A. (2007) Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8, 359–368.
63. Hill, J. A., Feuerer, M., Tash, K., Haxhinasto, S., Perez, J., Melamed, R., et al. (2007) Foxp3 transcription-factor-dependent and-indepen-dent regulation of the regulatory T cell transcriptional signature. Immunity 27, 786–800.
64. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886.
65. Apostolou, I. and von Boehmer, H. (2004) In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401–1408.
66. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235–247.
67. + regulatory cell activation and function by dendritic cells. Int. Immunol. 16, 1769–1780.
68. Pasare, C. and Medzhitov, R. (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033–1036.
69. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B. (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179–189.
70. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238.
71. Laurence, A., Tato, C. M., Davidson, T. S., Kanno, Y., Chen, Z., Yao, Z., et al. (2007) Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371–381.
72. Wellcome Trust Case Control Consortium. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661–678.
73. Encinas, J. A., Wicker, L. S., Peterson, L. B., Mukasa, A., Teuscher, C., Sobel, R., et al. (1999) QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2. Nat. Genet. 21, 158–160.
74. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212, 8–27.
75. Nishikawa, H. and Sakaguchi, S. (2010) Regulatory T cells in tumor immunity. Int. J. Cancer 127, 759–777.
76. Li, Y., Zhao, X., Cheng, D., Haga, H., Tsuruyama, T., Wood, K., et al. (2008) The presence of FOXP3 expressing T cells within grafts of tolerance human liver transplant recipients. Transplantation 86, 1837–1843.